Mayrink Giardini H, Caparbo V, de Castro I, Toledo A, Barbas C, Shinjo S
Clinics (Sao Paulo). 2024; 79:100524.
PMID: 39476516
PMC: 11565043.
DOI: 10.1016/j.clinsp.2024.100524.
Banerjee P, Jain A, Kumar U, Senapati S
Rheumatol Int. 2021; 41(12):2069-2089.
PMID: 34635927
DOI: 10.1007/s00296-021-05011-1.
Theprungsirikul J, Skopelja-Gardner S, Rigby W
J Transl Autoimmun. 2021; 4:100105.
PMID: 34142075
PMC: 8187252.
DOI: 10.1016/j.jtauto.2021.100105.
Callea F, Francalanci P, Giovannoni I
Int J Mol Sci. 2021; 22(11).
PMID: 34071368
PMC: 8198767.
DOI: 10.3390/ijms22115778.
Pesce F, Stea E, Rossini M, Fiorentino M, Piancone F, Infante B
Front Med (Lausanne). 2021; 7:582272.
PMID: 33738291
PMC: 7960664.
DOI: 10.3389/fmed.2020.582272.
Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.
Kawasaki A, Tsuchiya N
Genes Immun. 2021; 22(1):1-11.
PMID: 33686257
DOI: 10.1038/s41435-021-00123-x.
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US.
Sandhaus R, Strange C, Stone G, Runken M, Blanchette C, Howden R
Int J Chron Obstruct Pulmon Dis. 2020; 15:2389-2397.
PMID: 33116454
PMC: 7547287.
DOI: 10.2147/COPD.S263297.
Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?.
Crossley D, Stockley R, Sapey E
Drugs Aging. 2019; 36(9):823-840.
PMID: 31179525
DOI: 10.1007/s40266-019-00684-7.
Advances in managing COPD related to α -antitrypsin deficiency: An under-recognized genetic disorder.
Craig T, Henao M
Allergy. 2018; 73(11):2110-2121.
PMID: 29984428
PMC: 6282978.
DOI: 10.1111/all.13558.
Rare case of eosinophilic granulomatosis with polyangiitis in two patients with α-1-antitrypsin deficiency (PiSZ).
Moxey J, Low E, Turner A
BMJ Case Rep. 2016; 2016.
PMID: 27118743
PMC: 4854129.
DOI: 10.1136/bcr-2015-214118.
Low Serum Alpha-Antitrypsin Associated with Anti-PR-3 ANCA in Autistic Children with GI Disease.
Russo A, Krigsman A, Jepson B, Wakefield A
Genomics Insights. 2015; 2:1-9.
PMID: 26244018
PMC: 4510608.
DOI: 10.4137/gei.s2918.
Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
Hilhorst M, van Paassen P, Cohen Tervaert J
J Am Soc Nephrol. 2015; 26(10):2314-27.
PMID: 25956510
PMC: 4587702.
DOI: 10.1681/ASN.2014090903.
Genetics of ANCA-associated Vasculitides.
Ugarte-Gil M, Espinoza L
Curr Rheumatol Rep. 2014; 16(7):428.
PMID: 24828480
DOI: 10.1007/s11926-014-0428-5.
ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity.
Sreih A, Mandhadi R, Aldaghlawi F, Khan A, Irshad V, Finn K
Clin Rheumatol. 2014; 34(5):943-8.
PMID: 24752347
DOI: 10.1007/s10067-014-2617-z.
[Genetic risk factors for vasculitis].
Holle J, Gross W
Internist (Berl). 2013; 55(2):128-34.
PMID: 24217527
DOI: 10.1007/s00108-013-3305-9.
Alpha1-antitrypsin deficiency: a clinical-genetic overview.
Abboud R, Nelson T, Jung B, Mattman A
Appl Clin Genet. 2013; 4:55-65.
PMID: 23776367
PMC: 3681178.
DOI: 10.2147/TACG.S10604.
α1-Antitrypsin deficiency in a patient diagnosed with granulomatosis with polyangiitis.
Inaty H, Arabelovic S
BMJ Case Rep. 2013; 2013.
PMID: 23625671
PMC: 3645134.
DOI: 10.1136/bcr-2013-009045.
Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis.
Mota A, Sahebghadam Lotfi A, Jamshidi A, Najavand S
Rheumatol Int. 2013; 34(4):553-8.
PMID: 23604680
DOI: 10.1007/s00296-013-2745-9.
Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
Korkmaz B, Lesner A, Letast S, Mahdi Y, Jourdan M, Dallet-Choisy S
Semin Immunopathol. 2013; 35(4):411-21.
PMID: 23385856
DOI: 10.1007/s00281-013-0362-z.
Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
Xiao H, Ciavatta D, Aylor D, Hu P, Pardo-Manuel de Villena F, Falk R
Am J Pathol. 2013; 182(4):1219-26.
PMID: 23384999
PMC: 3620395.
DOI: 10.1016/j.ajpath.2012.12.006.